Represented a global pharmaceutical company in patent infringement/invalidity litigation concerning a psoriasis treatment
Represented a global pharmaceutical company in patent infringement/invalidity litigation concerning an HIV treatment
Represented a global pharmaceutical company in patent infringement/invalidity litigation concerning an asthma treatment
Represented a global pharmaceutical company in patent infringement/invalidity litigation concerning a blood anticoagulant
Represented a global pharmaceutical company in patent invalidity litigation concerning pharmaceutical formulations
Represented a global pharmaceutical company in patent invalidity litigation concerning pharmaceutical impurities
Represented a domestic biopharmaceutical company in patent infringement/invalidity litigation concerning an anticancer drug
Represented a domestic biopharmaceutical company in patent infringement/invalidity litigation concerning a treatment for autoimmune diseases
Represented a domestic medical device manufacturer in patent infringement litigation concerning implants
Patent invalidity litigation concerning a natural-product health functional food
Represented a domestic game developer in patent infringement litigation concerning gaming technology
Represented a domestic chemical company in patent infringement/invalidity litigation concerning semiconductor materials
Represented a domestic broadcasting company in copyright infringement litigation concerning a film
Represented a domestic broadcasting company in copyright infringement litigation concerning a television drama
Represented a domestic public institution in copyright litigation relating to open access
Represented global companies in GMO (LMO) approval applications involving potatoes, canola, and sugarcane
Litigation seeking indemnity related to humidifier disinfectants
Capital Markets Act violation matter relating to a bio-medical device
Product liability litigation concerning pharmaceutical impurities
Representation in applications for reassessment of reimbursement adequacy (arthritis treatment, spherical activated carbon, etc.)
Litigation concerning pharmaceutical impurities
Administrative litigation relating to drug price reductions
Advisory matters concerning non-physician-owned hospitals
Pharmaceutical license agreements